Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration-Reference-Cited by-同舟云学术

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Published:2018-08-21 Issue: Volume: Page:1-20
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Smith Bryan¹,Kiessling Andrea¹,Lledo-Garcia Rocio¹^ORCID,Dixon Kate L.¹,Christodoulou Louis¹,Catley Matthew C.¹,Atherfold Paul¹,D’Hooghe Lena E.¹,Finney Helene¹,Greenslade Kevin¹,Hailu Hanna¹^ORCID,Kevorkian Lara¹,Lightwood Daniel¹^ORCID,Meier Christoph¹,Munro Rebecca¹,Qureshi Omar¹,Sarkar Kaushik¹,Shaw Sophie P.¹,Tewari Roohi¹,Turner Alison¹,Tyson Kerry¹,West Shauna¹,Shaw Stevan¹,Brennan Frank R.¹

Affiliation:

1. UCB Pharma, Slough, UK

Funder

UCB Pharma

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2018.1505464

Reference71 articles.

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue